PONCHIETTI, ROBERTO
PONCHIETTI, ROBERTO
AREA CRITICA MEDICO CHIRURGICA (attivo dal 01/01/2000 al 31/12/2012)
Bevacizumab and Weekly Docetaxel in Patients with Metastatic Castrate-Resistant Prostate Cancer Previously Exposed to Docetaxel
2011 Francini, Filippo; Pascucci, Alessandra; Francini, Edoardo; Bargagli, Gianluca; Conca, Raffaele; Licchetta, Antonella; Roviello, Giandomenico; Martellucci, Ignazio; Chiriacò, Giorgio; Miano, Salvatora Tindara; Marzocca, Giuseppe; Manganelli, Antonio; Ponchietti, Roberto; Savelli, Vinno; Petrioli, Roberto
Control of nephrotoxicity by hydration-diuresis, and of emesis by alizapride in patiens with bladder cancer
1987 B. Neri; S. Bartalucci; P. Rizzo; G. Nicita; R. Ponchietti
Cyclophosphamide, epidoxorubicin and Carboplatin as treatment for advanced-carcinoma of the bladder - a phase-ii study.
1994 Neri B; Nicita G; Stomaci N; Gemelli M; Intini C; Fiorelli C; Mottola A; Paoletti M; Ponchietti R; Raugei A; Trippitelli A; Vici I; Villari D; Grechi G
Docetaxel and epirubicin compared with docetaxel and prednisone in advanced castrate-resistant prostate cancer: a randomised phase II study
2011 Petrioli, R; Pascucci, A; Conca, R; Chiriacò, G; Francini, E; Bargagli, G; Fiaschi, A I; Manganelli, A; De Rubertis, G; Barbanti, G; Ponchietti, R; Francini, G
Endoluminal instillation of Epidoxorubicin as adjuvant treatment for upper urinary tract urothelial tumours
1996 R. Ponchietti; B. Neri; F. Di Loro; A. Raugei
Low-Dose Estramustine Phosphate and Concomitant Low-Dose Acetylsalicylic Acid in Heavily Pretreated Patients With Advanced Castration-Resistant Prostate Cancer
2015 Petrioli R; Roviello G; Fiaschi Ai; Laera L; Bianco V; Ponchietti R; Barbanti G; Francini E.
Male infertility. Histopathological aspects of testicular biopsy
1978 Lenzi R; Ponchietti R; Scarselli GF; Franchini M; Luciani L; Tonini M; Taddei G.L.; Colafranceschi M.
Melatonin as Biological Response Modifier in Cancer Patients
1998 B. Neri; V. de Leonardis; M. Gemelli; F. Di Loro; R. Ponchietti; A. Raugei; G. Cini
Phase II trial of weekly intravenous gemcitabine administration with interferon and interleukin-2 immunotherapy for metastatic renal cell cancer.
2002 Neri B;Doni L;Gemelli MT;Fulignati C;Turrini M;Di Cello V;Dominici A;Maleci M;Mottola A;Ponchietti R;Raugei A;Valsuani G;Cini G
Post-ureterolithotomy ureteral stenosis: therapeutic assessments based on dynamic and diuretic radiological studies
1982 Masini G; Nicita G; Ponchietti R; Tosto A
Priapism due to sacrococcygeal chordoma metastasis treated with radiation therapy
2005 MONDAINI N; MONDAINI A; MONDAINI L; L. LIVI; GIUBILEI G; PONCHIETTI R
Role of chemotherapy in the treatment of metastatic castration-resistant prostate cancer patients who have progressed after abiraterone acetate
2015 Petrioli R; Francini E; Ponchietti R; Roviello G; Laera L; Fiaschi Ai
The role of lomefloxacin in the treatment of chronic prostatitis.
2001 S.Scelzi;F.Travaglini;S.Nerozzi;A.Dominici;R.Ponchietti;A.Novelli;M.Rizzo
Tipizzazione ecografica del tessuto prostatico mediante analisi spettrale: sperimentazione in vitro nel tumore della prostata.
2003 G. Bruno; A. Bertaccini; S. Granchi; L. Breschi; E. Biagi; F. Di Loro; R. Ponchietti; L. Masotti; G. Martorana
Tolerability of cabazitaxel in patients with metastatic castration-resistant prostate cancer progressing after docetaxel and abiraterone acetate: a single-institution experience
2015 Francini E; Fiaschi Ai; Petrioli R; Laera L; Bianco V; Ponchietti R; Roviello G.
Weekly epidoxorubicin therapy in hormone-refractory metastatic prostate cancer.
1997 B Neri; G Barbagli; P Bellesi; R Di Loro; V Lombardi; C Lombardo; T Magrini; A Mottola; G Nicita; E Palminteri; R Ponchietti; A Raugei; C Intini
Weekly paclitaxel and epirubicin in the treatment of symptomatic hormone-refractory advanced prostate carcinoma:a phase II trial
2005 B. Neri; G. Cipriani; C. Fulignati; M. Turrini; R. Ponchietti; R. Bartoletti; A. Della Melina; V. Di Cello; D. Maleci; A. Raugei; D. Villari; G. Nicita
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Bevacizumab and Weekly Docetaxel in Patients with Metastatic Castrate-Resistant Prostate Cancer Previously Exposed to Docetaxel | 2011 | Francini, Filippo; Pascucci, Alessandra; Francini, Edoardo; Bargagli, Gianluca; Conca, Raffaele; Licchetta, Antonella; Roviello, Giandomenico; Martellucci, Ignazio; Chiriacò, Giorgio; Miano, Salvatora Tindara; Marzocca, Giuseppe; Manganelli, Antonio; Ponchietti, Roberto; Savelli, Vinno; Petrioli, Roberto | |
| Control of nephrotoxicity by hydration-diuresis, and of emesis by alizapride in patiens with bladder cancer | 1987 | B. Neri; S. Bartalucci; P. Rizzo; G. Nicita; R. Ponchietti | |
| Cyclophosphamide, epidoxorubicin and Carboplatin as treatment for advanced-carcinoma of the bladder - a phase-ii study. | 1994 | Neri B; Nicita G; Stomaci N; Gemelli M; Intini C; Fiorelli C; Mottola A; Paoletti M; Ponchietti R; Raugei A; Trippitelli A; Vici I; Villari D; Grechi G | |
| Docetaxel and epirubicin compared with docetaxel and prednisone in advanced castrate-resistant prostate cancer: a randomised phase II study | 2011 | Petrioli, R; Pascucci, A; Conca, R; Chiriacò, G; Francini, E; Bargagli, G; Fiaschi, A I; Manganelli, A; De Rubertis, G; Barbanti, G; Ponchietti, R; Francini, G | |
| Endoluminal instillation of Epidoxorubicin as adjuvant treatment for upper urinary tract urothelial tumours | 1996 | R. Ponchietti; B. Neri; F. Di Loro; A. Raugei | |
| Low-Dose Estramustine Phosphate and Concomitant Low-Dose Acetylsalicylic Acid in Heavily Pretreated Patients With Advanced Castration-Resistant Prostate Cancer | 2015 | Petrioli R; Roviello G; Fiaschi Ai; Laera L; Bianco V; Ponchietti R; Barbanti G; Francini E. | |
| Male infertility. Histopathological aspects of testicular biopsy | 1978 | Lenzi R; Ponchietti R; Scarselli GF; Franchini M; Luciani L; Tonini M; Taddei G.L.; Colafranceschi M. | |
| Melatonin as Biological Response Modifier in Cancer Patients | 1998 | B. Neri; V. de Leonardis; M. Gemelli; F. Di Loro; R. Ponchietti; A. Raugei; G. Cini | |
| Phase II trial of weekly intravenous gemcitabine administration with interferon and interleukin-2 immunotherapy for metastatic renal cell cancer. | 2002 | Neri B;Doni L;Gemelli MT;Fulignati C;Turrini M;Di Cello V;Dominici A;Maleci M;Mottola A;Ponchietti R;Raugei A;Valsuani G;Cini G | |
| Post-ureterolithotomy ureteral stenosis: therapeutic assessments based on dynamic and diuretic radiological studies | 1982 | Masini G; Nicita G; Ponchietti R; Tosto A | |
| Priapism due to sacrococcygeal chordoma metastasis treated with radiation therapy | 2005 | MONDAINI N; MONDAINI A; MONDAINI L; L. LIVI; GIUBILEI G; PONCHIETTI R | |
| Role of chemotherapy in the treatment of metastatic castration-resistant prostate cancer patients who have progressed after abiraterone acetate | 2015 | Petrioli R; Francini E; Ponchietti R; Roviello G; Laera L; Fiaschi Ai | |
| The role of lomefloxacin in the treatment of chronic prostatitis. | 2001 | S.Scelzi;F.Travaglini;S.Nerozzi;A.Dominici;R.Ponchietti;A.Novelli;M.Rizzo | |
| Tipizzazione ecografica del tessuto prostatico mediante analisi spettrale: sperimentazione in vitro nel tumore della prostata. | 2003 | G. Bruno; A. Bertaccini; S. Granchi; L. Breschi; E. Biagi; F. Di Loro; R. Ponchietti; L. Masotti; G. Martorana | |
| Tolerability of cabazitaxel in patients with metastatic castration-resistant prostate cancer progressing after docetaxel and abiraterone acetate: a single-institution experience | 2015 | Francini E; Fiaschi Ai; Petrioli R; Laera L; Bianco V; Ponchietti R; Roviello G. | |
| Weekly epidoxorubicin therapy in hormone-refractory metastatic prostate cancer. | 1997 | B Neri; G Barbagli; P Bellesi; R Di Loro; V Lombardi; C Lombardo; T Magrini; A Mottola; G Nicita; E Palminteri; R Ponchietti; A Raugei; C Intini | |
| Weekly paclitaxel and epirubicin in the treatment of symptomatic hormone-refractory advanced prostate carcinoma:a phase II trial | 2005 | B. Neri; G. Cipriani; C. Fulignati; M. Turrini; R. Ponchietti; R. Bartoletti; A. Della Melina; V. Di Cello; D. Maleci; A. Raugei; D. Villari; G. Nicita |